Suchergebnisse - "Wendtner Clemens-M."

PubPharm (55)

1

MARCKS affects cell motility and response to BTK inhibitors in CLL

enthalten in: Blood | 2021

von Beckmann, L. | Berg, V. | Dickhut, C. | +24

CommentIn: Blood. 2021 Aug 19;138(7):503-504. - PMID 34410355

2

Preinfection laboratory parameters may predict COVID-19 severity in tumor patients

enthalten in: Cancer medicine | 2021

von Kiani, A. | Roesch, R. | Wendtner, C. | +20

3

Preinfection laboratory parameters may predict COVID‐19 severity in tumor patients

enthalten in: Cancer Medicine | 2021

von Kiani, A. | Roesch, R. | Wendtner, C. | +20

4

COVID-19 among fit patients with CLL treated with venetoclax-based combinations

enthalten in: Leukemia | 2020

von Fürstenau, M. | Langerbeins, P. | De Silva, N. | +19

5

Outcome of patients aged 80 years or older treated for chronic lymphocytic leukaemia

enthalten in: British journal of haematology | 2018

von Al-Sawaf, O. | Bahlo, J. | Robrecht, S. | +12

6

Venetoclax and obinutuzumab in chronic lymphocytic leukemia

enthalten in: Blood | 2017

von Fischer, K. | Al-Sawaf, O. | Fink, A. | +24

ErratumIn: Blood. 2017 Jul 13;130(2):232. - PMID 28705863

7

Severe motor aphasia after reinfusion of cryopreserved autologous stem cells after myeloablative conditioning

enthalten in: Transfusion | 2016

von Hausmann, A. | Fischer, N. | Breitkopf, S. | +5

8

Safety and efficacy of different lenalidomide starting doses in patients with relapsed or refractory chronic lymphocytic leukemia : results of an international multicenter double-blinded randomized phase II trial

enthalten in: Leukemia & lymphoma | 2016

von Wendtner, C. | Hallek, M. | Fraser, G. | +13

CommentIn: Leuk Lymphoma. 2016;57(6):1247-8. - PMID 26732524

9

Safety and efficacy of different lenalidomide starting doses in patients with relapsed or refractory chronic lymphocytic leukemia: results of an international multicenter double-blinded randomized phase II trial

enthalten in: Leukemia & lymphoma | 2016

von Wendtner, C. | Hallek, M. | Fraser, G. | +13

10

Safety and efficacy of different lenalidomide starting doses in patients with relapsed or refractory chronic lymphocytic leukemia: results of an international multicenter double-blinded randomized phase II trial

enthalten in: Leukemia & lymphoma | 2016

von Wendtner, C. | Hallek, M. | Fraser, G. | +13

1
2
3
4
5
6
Nächster »
[6]